Literature DB >> 15094479

Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder.

Richard Delorme1, Marie-Odile Krebs, Nadia Chabane, Isabelle Roy, Bruno Millet, Marie Christine Mouren-Simeoni, Wolfgang Maier, Thomas Bourgeron, Marion Leboyer.   

Abstract

Several lines of evidence suggest that obsessive compulsive disorder (OCD) could be the consequence of glutamatergic dysfunction. We performed a case-control study in 156 patients and 141 controls and the transmission disequilibrium test in 124 parent-offspring trios to search for association between OCD and two kainate receptors, GRIK2 and GRIK3. Using three single nucleotide polymorphisms (SNP) in GRIK2 and one in GRIK3, we found no evidence for association in case-control or family-based analyses. Only the GRIK2 SNP I867, recently associated with autism, was less transmitted than expected (p < 0.03), supporting a functional role for this variant. These findings suggest the need for further investigation of the role of GRIK2 in OCD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094479     DOI: 10.1097/00001756-200403220-00025

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  32 in total

1.  Family-based genetic association study of DLGAP3 in Tourette Syndrome.

Authors:  Jacquelyn Crane; Jesen Fagerness; Lisa Osiecki; Boyd Gunnell; S Evelyn Stewart; David L Pauls; Jeremiah M Scharf
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-11-02       Impact factor: 3.568

Review 2.  Autism spectrum and obsessive-compulsive disorders: OC behaviors, phenotypes and genetics.

Authors:  Suma Jacob; Angeli Landeros-Weisenberger; James F Leckman
Journal:  Autism Res       Date:  2009-12       Impact factor: 5.216

3.  Association between the NMDA glutamate receptor GRIN2B gene and obsessive-compulsive disorder.

Authors:  Pino Alonso; Mónica Gratacós; Cinto Segalàs; Georgia Escaramís; Eva Real; Mónica Bayés; Javier Labad; Clara López-Solà; Xavier Estivill; José M Menchón
Journal:  J Psychiatry Neurosci       Date:  2012-07       Impact factor: 6.186

Review 4.  Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment.

Authors:  Christopher Pittenger; Michael H Bloch; Kyle Williams
Journal:  Pharmacol Ther       Date:  2011-09-22       Impact factor: 12.310

5.  Kainate Receptors Inhibit Glutamate Release Via Mobilization of Endocannabinoids in Striatal Direct Pathway Spiny Projection Neurons.

Authors:  John J Marshall; Jian Xu; Anis Contractor
Journal:  J Neurosci       Date:  2018-03-14       Impact factor: 6.167

Review 6.  Brain imaging in pediatric obsessive-compulsive disorder.

Authors:  Frank P MacMaster; Joseph O'Neill; David R Rosenberg
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-11       Impact factor: 8.829

Review 7.  The genetic studies of obsessive-compulsive disorder and its future directions.

Authors:  Se Joo Kim; Chan-Hyung Kim
Journal:  Yonsei Med J       Date:  2006-08-31       Impact factor: 2.759

Review 8.  Ionotropic glutamate receptors & CNS disorders.

Authors:  Derek Bowie
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-04       Impact factor: 4.388

Review 9.  Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.

Authors:  Christopher Pittenger; John H Krystal; Vladimir Coric
Journal:  NeuroRx       Date:  2006-01

10.  Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder.

Authors:  Jonathan T Ting; Guoping Feng
Journal:  Curr Chem Genomics       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.